Cargando…

Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension

Angiotensin II is a key player in the pathogenesis of renovascular hypertension, a condition associated with endothelial dysfunction. We investigated aliskiren (ALSK) and L-arginine treatment both alone and in combination on blood pressure (BP), and vascular reactivity in aortic rings. Hypertension...

Descripción completa

Detalles Bibliográficos
Autores principales: Santuzzi, C.H., Tiradentes, R.V., Mengal, V., Claudio, E.R.G., Mauad, H., Gouvea, S.A., Abreu, G.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288495/
https://www.ncbi.nlm.nih.gov/pubmed/25493385
http://dx.doi.org/10.1590/1414-431X20144191
_version_ 1782351981991428096
author Santuzzi, C.H.
Tiradentes, R.V.
Mengal, V.
Claudio, E.R.G.
Mauad, H.
Gouvea, S.A.
Abreu, G.R.
author_facet Santuzzi, C.H.
Tiradentes, R.V.
Mengal, V.
Claudio, E.R.G.
Mauad, H.
Gouvea, S.A.
Abreu, G.R.
author_sort Santuzzi, C.H.
collection PubMed
description Angiotensin II is a key player in the pathogenesis of renovascular hypertension, a condition associated with endothelial dysfunction. We investigated aliskiren (ALSK) and L-arginine treatment both alone and in combination on blood pressure (BP), and vascular reactivity in aortic rings. Hypertension was induced in 40 male Wistar rats by clipping the left renal artery. Animals were divided into Sham, 2-kidney, 1-clip (2K1C) hypertension, 2K1C+ALSK (ALSK), 2K1C+L-arginine (L-arg), and 2K1C+ALSK+L-arginine (ALSK+L-arg) treatment groups. For 4 weeks, BP was monitored and endothelium-dependent and independent vasoconstriction and relaxation were assessed in aortic rings. ALSK+L-arg reduced BP and the contractile response to phenylephrine and improved acetylcholine relaxation. Endothelium removal and incubation with N-nitro-L-arginine methyl ester (L-NAME) increased the response to phenylephrine in all groups, but the effect was greater in the ALSK+L-arg group. Losartan reduced the contractile response in all groups, apocynin reduced the contractile response in the 2K1C, ALSK and ALSK+L-arg groups, and incubation with superoxide dismutase reduced the phenylephrine response in the 2K1C and ALSK groups. eNOS expression increased in the 2K1C and L-arg groups, and iNOS was increased significantly only in the 2K1C group compared with other groups. AT(1) expression increased in the 2K1C compared with the Sham, ALSK and ALSK+L-arg groups, AT(2) expression increased in the ALSK+L-arg group compared with the Sham and L-arg groups, and gp91phox decreased in the ALSK+L-arg group compared with the 2K1C and ALSK groups. In conclusion, combined ALSK+L-arg was effective in reducing BP and preventing endothelial dysfunction in aortic rings of 2K1C hypertensive rats. The responsible mechanisms appear to be related to the modulation of the local renin-angiotensin system, which is associated with a reduction in endothelial oxidative stress.
format Online
Article
Text
id pubmed-4288495
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Associação Brasileira de Divulgação Científica
record_format MEDLINE/PubMed
spelling pubmed-42884952015-01-21 Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension Santuzzi, C.H. Tiradentes, R.V. Mengal, V. Claudio, E.R.G. Mauad, H. Gouvea, S.A. Abreu, G.R. Braz J Med Biol Res Biomedical Sciences Angiotensin II is a key player in the pathogenesis of renovascular hypertension, a condition associated with endothelial dysfunction. We investigated aliskiren (ALSK) and L-arginine treatment both alone and in combination on blood pressure (BP), and vascular reactivity in aortic rings. Hypertension was induced in 40 male Wistar rats by clipping the left renal artery. Animals were divided into Sham, 2-kidney, 1-clip (2K1C) hypertension, 2K1C+ALSK (ALSK), 2K1C+L-arginine (L-arg), and 2K1C+ALSK+L-arginine (ALSK+L-arg) treatment groups. For 4 weeks, BP was monitored and endothelium-dependent and independent vasoconstriction and relaxation were assessed in aortic rings. ALSK+L-arg reduced BP and the contractile response to phenylephrine and improved acetylcholine relaxation. Endothelium removal and incubation with N-nitro-L-arginine methyl ester (L-NAME) increased the response to phenylephrine in all groups, but the effect was greater in the ALSK+L-arg group. Losartan reduced the contractile response in all groups, apocynin reduced the contractile response in the 2K1C, ALSK and ALSK+L-arg groups, and incubation with superoxide dismutase reduced the phenylephrine response in the 2K1C and ALSK groups. eNOS expression increased in the 2K1C and L-arg groups, and iNOS was increased significantly only in the 2K1C group compared with other groups. AT(1) expression increased in the 2K1C compared with the Sham, ALSK and ALSK+L-arg groups, AT(2) expression increased in the ALSK+L-arg group compared with the Sham and L-arg groups, and gp91phox decreased in the ALSK+L-arg group compared with the 2K1C and ALSK groups. In conclusion, combined ALSK+L-arg was effective in reducing BP and preventing endothelial dysfunction in aortic rings of 2K1C hypertensive rats. The responsible mechanisms appear to be related to the modulation of the local renin-angiotensin system, which is associated with a reduction in endothelial oxidative stress. Associação Brasileira de Divulgação Científica 2014-10-24 /pmc/articles/PMC4288495/ /pubmed/25493385 http://dx.doi.org/10.1590/1414-431X20144191 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Biomedical Sciences
Santuzzi, C.H.
Tiradentes, R.V.
Mengal, V.
Claudio, E.R.G.
Mauad, H.
Gouvea, S.A.
Abreu, G.R.
Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension
title Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension
title_full Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension
title_fullStr Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension
title_full_unstemmed Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension
title_short Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension
title_sort combined aliskiren and l-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension
topic Biomedical Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288495/
https://www.ncbi.nlm.nih.gov/pubmed/25493385
http://dx.doi.org/10.1590/1414-431X20144191
work_keys_str_mv AT santuzzich combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension
AT tiradentesrv combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension
AT mengalv combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension
AT claudioerg combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension
AT mauadh combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension
AT gouveasa combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension
AT abreugr combinedaliskirenandlargininetreatmenthasantihypertensiveeffectsandpreventsvascularendothelialdysfunctioninamodelofrenovascularhypertension